CHITCherubim Interests Inc
The schedule
- Thu15Oct
Estimated Q3 2026 earnings release from a baseline of $0.0001, focusing on critical cash flow generation. With Net Debt / EBITDA at 12.5x and deeply negative equity, the market will scrutinize any signs of operational turnaround to capture federal infrastructure spending under President Trump, or face further insolvency risks dropping the stock to $0.00001.
- Thu10Dec
Extreme leverage and limited cash reserves necessitate a highly dilutive capital raise or debt restructuring from the $0.00001 level. Any failure to secure financing opens the door to a $0.000001 floor.
- Mon15Feb
Estimated Full Year 2026 results evaluated from a distressed $0.000001 level. Focus will rest entirely on the auditor's going concern opinion. Survival implies a target of $0.00.000005, while continued cash bleed leads to a near-total wipeout at $0.0000001.
